Literature DB >> 3496596

Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection.

D W Bahler, J G Frelinger, L W Harwell, E M Lord.   

Abstract

Cultured cells of the murine lung carcinoma called line 1 express very low levels of H-2 class I antigens and are resistant to lysis mediated by alloreactive T cells. In order to investigate how the expression of class I antigens affects the in vivo growth of this spontaneous tumor, H-2Dp genes were transferred into line 1 cells. Cloned transfectants that displayed H-2Dp surface antigens were identified using flow cytometry. The transfected H-2Dp antigens appeared normal by two-dimensional gel electrophoresis and could also function as excellent targets for T-cell-mediated lysis in vitro. Marked differences in tumorigenicity (defined as tumor growth in immunologically competent hosts) were observed between the Dp transfected cells and untransfected or control transfected line 1 cells in syngeneic mice only if the animals had previously received injections of irradiated Dp transfectants. Expression of Dp antigens did not appreciably affect the growth of line 1 tumors in immunologically naive syngeneic mice or necessarily cause rejection in allogeneic mice. Our in vivo results show that increased expression of class I antigens can reduce the growth of tumors like line 1 that lack all class I antigens. Our results also suggest that increasing class I antigens alone on some spontaneous tumors deficient in expression will not by itself be sufficient for tumor rejection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496596      PMCID: PMC305130          DOI: 10.1073/pnas.84.13.4562

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Immunity to methylcholanthrene-induced sarcomas.

Authors:  R T PREHN; J M MAIN
Journal:  J Natl Cancer Inst       Date:  1957-06       Impact factor: 13.506

Review 2.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

3.  A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor.

Authors:  J M Yuhas; N H Pazmino; J O Proctor; R E Toya
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

4.  Absence of significant H-2 and beta 2-microglobulin mRNA expression by mouse embryonal carcinoma cells.

Authors:  D Morello; F Daniel; P Baldacci; Y Cayre; G Gachelin; P Kourilsky
Journal:  Nature       Date:  1982-03-18       Impact factor: 49.962

5.  Quantitative appraisal of H-2 products in T cell-mediated lysis by allogeneic and syngeneic effector cells.

Authors:  R C Kuppers; Z K Ballas; W R Green; C S Henney
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

6.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

Review 7.  Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.

Authors:  G Klein; E Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

8.  Characterization of a progressive tumor from C3H fibroblasts transformed in vitro with SV40 virus. Immunoresistance in vivo correlates with phenotypic loss of H-2Kk.

Authors:  L R Gooding
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

9.  Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer.

Authors:  K A Fleming; A McMichael; J A Morton; J Woods; J O McGee
Journal:  J Clin Pathol       Date:  1981-07       Impact factor: 3.411

10.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

View more
  7 in total

1.  Relation of H-2 expression on murine RCT(+) sarcoma cells to lung colonization and sensitivity to NK cells.

Authors:  K Masuyama; H Ochiai; S Ishizawa; K Tazawa; S Niwayama; M Fujimaki
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

2.  Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens.

Authors:  T VandenDriessche; M Bakkus; D Toussaint-Demylle; K Thielemans; H Verschueren; P De Baetselier
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

3.  Allogeneic H-2 antigen expression is insufficient for tumor rejection.

Authors:  G A Cole; G A Cole; V K Clements; E P Garcia; S Ostrand-Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Cis-acting elements determine the locus-specific shutoff of class I major histocompatibility genes in murine S49 lymphoma sublines.

Authors:  J B Keeney; T H Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Immunogenicity and immunosensitivity of ex vivo human carcinomas: interferon gamma and tumour necrosis factor alpha treatment of tumour cells potentiates their interaction with autologous blood lymphocytes.

Authors:  F Vánky; C Hising; K Sjöwall; B Larsson; L Rodriguez; L Orre; E Klein
Journal:  Cancer Immunol Immunother       Date:  1995-10       Impact factor: 6.968

6.  Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes.

Authors:  M A Alexander; C A Damico; K M Wieties; T H Hansen; J M Connolly
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

7.  Crabp2 Promotes Metastasis of Lung Cancer Cells via HuR and Integrin β1/FAK/ERK Signaling.

Authors:  Jun-I Wu; Yi-Pei Lin; Chien-Wei Tseng; Hui-Jane Chen; Lu-Hai Wang
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.